Magnetic polyelectrolyte-based composites with dual anticoagulant and thrombolytic properties: towards optimal composition

Benjamin EJ, Virani SS, Callaway CW et al. (2017) Heart disease and stroke statistics—2017 update Moodie DS (2016) The global burden of cardiovascular disease. Congenit Heart Dis 11:213 Nichols M, Townsend N, Scarborough P, Rayner M (2013) Cardiovascular disease in Europe: epidemiological update Moser KM, Hajjar GC(1960) The combined use of fibrinolytic and anticoagulant agents. Laboratory and clinical considerations* Am J Cardiol 6:496–502 Manco-Johnson MJ, Nuss R, Hays T et al. (2000) Combined thrombolytic and anticoagulant therapy for venous thrombosis in children. J Pediatr 136:446–453 Simoons ML, Krzemiñska-Pakula M, Alonso A et al. (2002) Improved reperfusion and clinical outcome with enoxaparin as an adjunct to streptokinase thrombolysis in acute myocardial infarction: the AMI-SK study. Eur Heart J 23:1282–1290 Antman EM, Anbe DT, Armstrong PW et al. (2004) ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction—executive summary. A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction) Circulation 110:588–636 Théroux P, Welsh RC (2003) Meta-analysis of randomized trials comparing enoxaparin versus unfractionated heparin as adjunctive therapy to fibrinolysis in ST-elevation acute myocardial infarction. Am J Cardiol 91:860–864 Zamanlu M, Farhoudi M, Eskandani M et al. (2018) Recent advances in targeted delivery of tissue plasminogen activator for enhanced thrombolysis in ischaemic stroke. J Drug Target 26:95–109 Colasuonno M, Palange AL, Aid R et al. (2018) Erythrocyte-inspired discoidal polymeric nanoconstructs carrying tissue plasminogen activator for the enhanced lysis of blood clots. ACS Nano 12:12224–12237 Chapurina YE, Drozdov AS, Popov I et al. (2016) Streptokinase@alumina nanoparticles as a promising thrombolytic colloid with prolonged action. J Mater Chem B 4:5921–5928 Voros E, Cho M, Ramirez M et al. (2015) TPA immobilization on iron oxide nanocubes and localized magnetic hyperthermia accelerate blood clot lysis. Adv Funct Mater 25:1709–1718 Jeon JK, Han SM, Min SK, et al (2016) Coulomb nanoradiator-mediated, site-specific thrombolytic proton treatment with a traversing pristine Bragg peak. Sci Rep. https://doi.org/10.1038/srep37848 Varna M, Juenet M, Bayles R, et al (2015) Nanomedicine as a strategy to fight thrombotic diseases. Futur Sci OA. https://doi.org/10.4155/fso.15.46 Drozdov AS, Vinogradov VV, Dudanov IP, Vinogradov VV (2016) Leach-proof magnetic thrombolytic nanoparticles and coatings of enhanced activity. Sci Rep 6:28199 Andreeva YI, Drozdov AS, Avnir D, Vinogradov VV (2018) Enzymatic nanocomposites with radio frequency field-modulated activity. ACS Biomater Sci Eng 4:3962–3967 Ji J, Ji SY, Yang JA et al. (2012) Ultrasound-targeted transfection of tissue-type plasminogen activator gene carried by albumin nanoparticles to dog myocardium to prevent thrombosis after heart mechanical valve replacement. Int J Nanomedicine 7:2911–2919 Vinogradov VV, Drozdov AS, Mingabudinova LR et al. (2018) Composites based on heparin and MIL-101(Fe): The drug releasing depot for anticoagulant therapy and advanced medical nanofabrication. J Mater Chem B 6:2450–2459 Epshtein M, Korin N (2017) Shear targeted drug delivery to stenotic blood vessels. J Biomech 50:217–221. Li C, Du H, Yang A, et al (2017) Thrombosis-responsive thrombolytic coating based on thrombin-degradable tissue plasminogen activator (t-PA) nanocapsules. Adv Funct Mater. https://doi.org/10.1002/adfm.201703934 Lippi G, Mattiuzzi C, Favaloro EJ (2013) Novel and emerging therapies: thrombus-targeted fibrinolysis. Semin Thromb Hemost 39:48–58 Roy K, Srivastwa AK, Ghosh CK (2019) Anticoagulant, thrombolytic and antibacterial activities of Euphorbia acruensis latex-mediated bioengineered silver nanoparticles. Green Process Synth 8:590–599 Lateef A, Folarin BI, Oladejo SM et al. (2018) Characterization, antimicrobial, antioxidant, and anticoagulant activities of silver nanoparticles synthesized from Petiveria alliacea L. leaf extract. Prep Biochem Biotechnol 48:646–652 Lateef A, Ojo SA, Folarin BI et al. (2016) Kolanut (Cola nitida) mediated synthesis of silver–gold alloy nanoparticles: antifungal, catalytic, larvicidal and thrombolytic applications. J Clust Sci 27:1561–1577 Gerber A, Bundschuh M, Klingelhofer D, Groneberg DA (2013) Gold nanoparticles: recent aspects for human toxicology. J Occup Med Toxicol 8:32 Gao W, Feng X, Pei A et al. (2014) Bioinspired helical microswimmers based on vascular plants. Nano Lett 14:305–310. Gong D, Cai J, Celi N et al. (2018) Bio-inspired magnetic helical microswimmers made of nickel-plated Spirulina with enhanced propulsion velocity. J Magn Magn Mater 468:148–154 Jeong S, Choi H, Go G et al. (2016) Penetration of an artificial arterial thromboembolism in a live animal using an intravascular therapeutic microrobot system. Med Eng Phys 38:403–410 Khalil ISM, Adel A, Mahdy D et al. (2019) Magnetic localization and control of helical robots for clearing superficial blood clots. APL Bioeng 3:026104 Daffertshofer M, Gass A, Ringleb P et al. (2005) Transcranial low-frequency ultrasound-mediated thrombolysis in brain ischemia: Increased risk of hemorrhage with combined ultrasound and tissue plasminogen activator - Results of a phase II clinical trial. Stroke 36:1441–1446 Netto CGCM, Toma HE, Andrade LH (2013) Superparamagnetic nanoparticles as versatile carriers and supporting materials for enzymes. J Mol Catal. B Enzym 85–86:71–92 Ziv O, Lublin-Tennenbaum T, Margel S (2009) Synthesis and characterization of thrombin conjugated γ-Fe 2O3 magnetic nanoparticles for hemostasis. Adv Eng Mater 11:B251–B260 Anastasova EI, Prilepskii AY, Fakhardo AF et al. (2018) Magnetite nanocontainers: toward injectable highly magnetic materials for targeted drug delivery. ACS Appl Mater Interfaces 10:30040–30044 Neuberger T, Schöpf B, Hofmann H et al. (2005) Superparamagnetic nanoparticles for biomedical applications: possibilities and limitations of a new drug delivery system. J Magn Magn Mater 293:483–496 Gupta AK, Gupta M (2005) Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials 26:3995–4021 Figuerola A, Di Corato R, Manna L, Pellegrino T (2010) From iron oxide nanoparticles towards advanced iron-based inorganic materials designed for biomedical applications. Pharmacol Res 62:126–143 Márquez F, Herrera GM, Campo T et al. (2012) Preparation of hollow magnetite microspheres and their applications as drugs carriers. Nanoscale Res Lett 7:1–11 Anastasova EI, Ivanovski V, Fakhardo AF et al. (2017) A pure magnetite hydrogel: synthesis, properties and possible applications. Soft Matter 13:8651–8660 Drozdov AS, Volodina KV, Vinogradov VV, Vinogradov VV (2015) Biocomposites for wound-healing based on sol-gel magnetite. RSC Adv 5:82992–82997 Cheng R, Huang W, Huang L et al. (2014) Acceleration of tissue plasminogen activator-mediated thrombolysis by magnetically powered nanomotors. ACS Nano 8:7746–7754 Liu M, Pan L, Piao H et al. (2015) Magnetically actuated wormlike nanomotors for controlled cargo release. ACS Appl Mater Interfaces 7:26017–26021 Weissig V, Pettinger TK, Murdock N (2014) Nanopharmaceuticals (part 1): products on the market. Int J Nanomedicine 9:4357–4373 Prilepskii AY, Fakhardo AF, Drozdov AS et al. (2018) Urokinase-conjugated magnetite nanoparticles as a promising drug delivery system for targeted thrombolysis: synthesis and preclinical evaluation. ACS Appl Mater Interfaces 10:36764–36775. Drozdov AS, Ivanovski V, Avnir D, Vinogradov VV (2016) A universal magnetic ferrofluid: Nanomagnetite stable hydrosol with no added dispersants and at neutral pH. J Colloid Interface Sci 468:307–312 Shapovalova OE, Drozdov AS, Bryushkova EA et al. (2018) Room-temperature fabrication of magnetite-boehmite sol-gel composites for heavy metal ions removal. Arab J Chem 13:1933–1944 Fadeeva OA, Panteleev MA, Karamzin SS et al. (2010) Thromboplastin immobilized on polystyrene surface exhibits kinetic characteristics close to those for the native protein and activates in vitro blood coagulation similarly to thromboplastin on fibroblasts. Biochem 75:734–743 Bhattacharjee S (2016) DLS and zeta potential - What they are and what they are not? J Control Release 235:337–351 Gracheva MA, Urnova ES, Sinauridze EI et al. (2015) Thromboelastography, thrombin generation test and thrombodynamics reveal hypercoagulability in patients with multiple myeloma. Leuk Lymphoma 56:3418–3425 Odziemkowski MS, Schuhmacher TT, Gillham RW, Reardon EJ (1998) Mechanism of oxide film formation on iron in simulating groundwater solutions: Raman spectroscopic studies. Corros Sci 40:371–389 Morimoto T, Yanai H, Nagao M (1976) Infrared spectra of ammonia adsorbed on zinc oxide. J Phys Chem. https://doi.org/10.1021/j100546a010 Fareed J, Hoppensteadt D, Walenga J et al. (2003) Pharmacodynamic and pharmacokinetic properties of enoxaparin: Implications for clinical practice. Clin Pharmacokinet 42:1043–1057 Boisson C, Gulino D, Jozefonvicz J et al. (1984) Antithrombic properties of insoluble modified polystyrene: Part I. Thromb Res 34:269–276 Dawes J (1988) Measurement of the affinities of heparins, naturally occurring glycosaminoglycans, and other sulfated polymers for antithrombin III and thrombin. Anal Biochem 174:177–186 Monien BH, Desai UR (2005) Antithrombin activation by nonsulfated, non-polysaccharide organic polymer. J Med Chem 48:1269–1273 Monien BH, Cheang KI, Desai UR (2005) Mechanism of poly(acrylic acid) acceleration of antithrombin inhibition of thrombin: Implications for the design of novel heparin mimics. J Med Chem 48:5360–5368 Steitz R, Leiner V, Siebrecht R,V, Klitzing R (2000) Influence of the ionic strength on the structure of polyelectrolyte films at the solid/liquid interface. Colloid Surface A 163:63–70 Glinel K, Moussa A, Jonas AM, Laschewsky A (2002) Influence of polyelectrolyte charge density on the formation of multilayers of strong polyelectrolytes at low ionic strength. Langmuir 18:1408–1412 Stephens RW, Myöhänen HT, Reisberg T et al. (1992) Heparin binding to the urokinase kringle domain. Biochemistry 31:7572–7579 Seregina EA, Nikulina OF, Tsvetaeva NV et al. (2014) Laboratory tests for coagulation system monitoring in a patient with β-thalassemia. Int J Hematol 99:588–596 Soshitova NP, Karamzin SS, Balandina AN et al. (2012) Predicting prothrombotic tendencies in sepsis using spatial clot growth dynamics. Blood Coagul Fibrinolysis 23:498–507 Seregina EA, Tsvetaeva NV, Nikulina OF et al. (2015) Eculizumab effect on the hemostatic state in patients with paroxysmal nocturnal hemoglobinuria. Blood Cells Mol Dis 54:144–150 Panteleev MA, Dashkevich NM, Ataullakhanov FI (2015) Hemostasis and thrombosis beyond biochemistry: Roles of geometry, flow and diffusion. Thromb Res 136:699–711 Ovanesov MV, Ananyeva NM, Panteleev MA et al. (2005) Initiation and propagation of coagulation from tissue factor-bearing cell monolayers to plasma: Initiator cells do not regulate spatial growth rate. J Thromb Haemost 3:321–331 Panteleev MA, Ovanesov MV, Kireev DA et al. (2006) Spatial propagation and localization of blood coagulation are regulated by intrinsic and protein C pathways, respectively. Biophys J 90:1489–1500 Parunov LA, Fadeeva OA, Balandina AN et al. (2011) Improvement of spatial fibrin formation by the anti-TFPI aptamer BAX499: Changing clot size by targeting extrinsic pathway initiation. J Thromb Haemost 9:1825–1834 Balandina AN, Shibeko AM, Kireev DA et al. (2011) Positive feedback loops for factor v and factor vii activation supply sensitivity to local surface tissue factor density during blood coagulation. Biophys J 101:1816–1824 Ovanesov MV, Panteleev MA, Sinauridze EI et al. (2008) Mechanisms of action of recombinant activated factor VII in the context of tissue factor concentration and distribution. Blood Coagul Fibrinolysis 19:743–755 Parunov LA, Soshitova NP, Fadeeva OA et al. (2014) Drug-drug interaction of the anti-TFPI aptamer BAX499 and factor VIII: Studies of spatial dynamics of fibrin clot formation in hemophilia A. Thromb Res 133:112–119 Lipets EN, Ataullakhanov FI (2015) Global assays of hemostasis in the diagnostics of hypercoagulation and evaluation of thrombosis risk. Thromb J. https://doi.org/10.1186/s12959-015-0038-0 Sinauridze EI, Kireev DA, Popenko NY et al. (2007) Platelet microparticle membranes have 50- to 100-fold higher specific procoagulant activity than activated platelets. Thromb Haemost 97:425–434 Lundqvist M, Stigler J, Elia G et al. (2008) Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proc Natl Acad Sci U S A 105:14265–14270 Gryshchuk V, Galagan N (2016) Silica nanoparticles effects on blood coagulation proteins and platelets. Biochem Res Int. https://doi.org/10.1155/2016/2959414 Sanfins E, Augustsson C, Dahlbäck B et al. (2014) Size-dependent effects of nanoparticles on enzymes in the blood coagulation cascade. Nano Lett 14:4736–4744 Urano T, Serizawa K, Takada Y et al. (1994) Heparin and heparan sulfate enhancement of the inhibitory activity of plasminogen activator inhibitor type 1 toward urokinase type plasminogen activator. Biochim Biophys Acta 1201:217–222. https://doi.org/10.1016/0304-4165(94)90043-4